Daiichi Sankyo Company, Limited (DSKYF)
Data as of September 10, 2026 · Drug Manufacturers - General
Stockbruh grade: Mixed 3/5 metrics rated Sunny
What does Daiichi Sankyo Company, Limited do?
Daiichi Sankyo, the pharmaceutical powerhouse based in Tokyo, is all about creating life-changing products. From cancer-fighting antibodies to diabetes treatments and skincare products like Minon, they've got it all covered. With a wide range of offerings in medicine, cosmetics, and even vaccines, Daiichi Sankyo is committed to keeping you healthy and glowing. 🌟.
Key Numbers
| Metric | Rating | What it means |
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ☀️ Strong | Net margin & return on equity |
| Growth | ☀️ Strong | Revenue & earnings trend |
| Earnings | ⛅ Moderate | EPS vs analyst expectations |
| Cash & Debt | ☀️ Strong | Balance sheet strength |
| Price | $17.56 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
Daiichi Sankyo, the pharmaceutical powerhouse based in Tokyo, is all about creating life-changing products. From cancer-fighting antibodies to diabetes treatments and skincare products like Minon, they've got it all covered. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Revenue and earnings are trending upward — Daiichi Sankyo Company, Limited appears to be growing. Sign up free for the full growth analysis including year-over-year comparisons and R&D investment data.
What's ahead?
Earnings are mixed. Sign up free for the full earnings picture including EPS history and analyst forecasts.